EN3-2. Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of NSCLC

Naoyuki Nogami; Delvys Rodriguez-Abreu; Yi-Long Wu; Michael Boyer; Marina C.Garassino; Tony S.K. Mok; Ying Cheng; Rina Hui; Dariusz M.Kowalski; Andrew G.Robinson; Julie R.Brahmer; Ticiana A.Leal; Gilberto Lopes; Byoung Chul Cho; Silvia Novello; Nir Peled; Gilberto de Castro Jr; Melanie A.Leiby; Diana Chirovsky; Jianxin Lin; M.Catherine Pietanza; Chinese University of Hong Kong

Journal article

EN3-2. Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of NSCLC

Naoyuki Nogami, Delvys Rodriguez-Abreu, Yi-Long Wu, Michael Boyer, Marina C.Garassino, Tony S.K. Mok, Ying Cheng, Rina Hui, Dariusz M.Kowalski, Andrew G.Robinson, …

Japanese Journal of Lung Cancer, Vol.62(6), pp.563-563

2022-11-07

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: EN3-2. Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of NSCLC
Creators: Naoyuki Nogami
Delvys Rodriguez-Abreu
Yi-Long Wu
Michael Boyer
Marina C.Garassino
Tony S.K. Mok
Ying Cheng
Rina Hui
Dariusz M.Kowalski
Andrew G.Robinson
Julie R.Brahmer
Ticiana A.Leal
Gilberto Lopes
Byoung Chul Cho
Silvia Novello
Nir Peled
Gilberto de Castro Jr
Melanie A.Leiby
Diana Chirovsky
Jianxin Lin
M.Catherine Pietanza
Chinese University of Hong Kong
Publication Details: Japanese Journal of Lung Cancer, Vol.62(6), pp.563-563
Publisher: The Japanese Lung Cancer Society
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: Japanese
Resource Type: Journal article
Record Identifier: 991031821348902976